Non-invasive panel tests for gastrointestinal motility monitoring within the MARS-500 Project

To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights. Breath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 19; no. 14; pp. 2208 - 2216
Main Author Roda, Aldo
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Co., Limited 2013
Subjects
Online AccessGet full text
ISSN1007-9327
2219-2840
2219-2840
DOI10.3748/wjg.v19.i14.2208

Cover

Abstract To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights. Breath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or H₂) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by ¹³C-octanoic acid and ¹³C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H₂-breath test, which was performed simultaneously with the ¹³C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of ¹³C-octanoic acid was used in the ¹³C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment. The experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations (i.e., increasing or decreasing trends) in the gastric emptying rates were detected using the ¹³C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the ¹³C-breath tests, the results of the inulin H₂-breath test were difficult to interpret because of the high variability of the H₂ concentration in the breath samples, even within the same subject. This variability suggested that the H₂-breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions (e.g., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, ¹³C-breath tests should therefore be preferred to H₂-breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation. Breath tests, especially those ¹³C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights.
AbstractList To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights.AIMTo develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights.Breath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or H₂) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by ¹³C-octanoic acid and ¹³C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H₂-breath test, which was performed simultaneously with the ¹³C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of ¹³C-octanoic acid was used in the ¹³C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment.METHODSBreath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or H₂) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by ¹³C-octanoic acid and ¹³C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H₂-breath test, which was performed simultaneously with the ¹³C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of ¹³C-octanoic acid was used in the ¹³C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment.The experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations (i.e., increasing or decreasing trends) in the gastric emptying rates were detected using the ¹³C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the ¹³C-breath tests, the results of the inulin H₂-breath test were difficult to interpret because of the high variability of the H₂ concentration in the breath samples, even within the same subject. This variability suggested that the H₂-breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions (e.g., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, ¹³C-breath tests should therefore be preferred to H₂-breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation.RESULTSThe experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations (i.e., increasing or decreasing trends) in the gastric emptying rates were detected using the ¹³C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the ¹³C-breath tests, the results of the inulin H₂-breath test were difficult to interpret because of the high variability of the H₂ concentration in the breath samples, even within the same subject. This variability suggested that the H₂-breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions (e.g., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, ¹³C-breath tests should therefore be preferred to H₂-breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation.Breath tests, especially those ¹³C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights.CONCLUSIONBreath tests, especially those ¹³C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights.
To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights. Breath tests based on the oral administration of ¹³C-labeled or hydrogen-producing substrates followed by the detection of their metabolites (¹³CO₂ or H₂) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by ¹³C-octanoic acid and ¹³C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H₂-breath test, which was performed simultaneously with the ¹³C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of ¹³C-octanoic acid was used in the ¹³C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment. The experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations (i.e., increasing or decreasing trends) in the gastric emptying rates were detected using the ¹³C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the ¹³C-breath tests, the results of the inulin H₂-breath test were difficult to interpret because of the high variability of the H₂ concentration in the breath samples, even within the same subject. This variability suggested that the H₂-breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions (e.g., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, ¹³C-breath tests should therefore be preferred to H₂-breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation. Breath tests, especially those ¹³C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights.
AIM: To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights. METHODS: Breath tests based on the oral administration of 13 C-labeled or hydrogen-producing substrates followed by the detection of their metabolites ( 13 CO 2 or H 2 ) in breath were used to measure gastrointestinal motility parameters during the 520-d spaceflight ground simulation within the MARS-500 Project. In particular, the gastric emptying rates of solid and liquid contents were evaluated by 13 C-octanoic acid and 13 C-acetate breath tests, respectively, whereas the orocecal transit time was assessed by an inulin H 2 -breath test, which was performed simultaneously with the 13 C-octanoic acid breath test. A ready-to-eat, standardized pre-packaged muffin containing 100 mg of 13 C-octanoic acid was used in the 13 C-octanoic acid breath test to avoid the extemporaneous preparation of solid meals. In addition, a cassette-type lateral flow immunoassay was employed to detect fecal calprotectin, a biomarker of intestinal inflammation. Because no items could be introduced into the simulator during the experiment, all materials and instrumentation required for test performance during the entire mission simulation had to be provided at the beginning of the experiment. RESULTS: The experiments planned during the simulation of a manned flight to Mars could be successfully performed by the crewmembers without any external assistance. No evident alterations ( i.e ., increasing or decreasing trends) in the gastric emptying rates were detected using the 13 C-breath tests during the mission simulation, as the gastric emptying half-times were in the range of those reported for healthy subjects. In contrast to the 13 C-breath tests, the results of the inulin H 2 -breath test were difficult to interpret because of the high variability of the H 2 concentration in the breath samples, even within the same subject. This variability suggested that the H 2 -breath test was strongly affected by external factors, which may have been related to the diet of the crewmembers or to environmental conditions ( e.g ., the accumulation of hydrogen in the simulator microenvironment). At least in closed microenvironments such as the MARS-500 simulator, 13 C-breath tests should therefore be preferred to H 2 -breath tests. Finally, the fecal calprotectin test showed significant alterations during the mission simulation: all of the crewmembers were negative for the test at the beginning of the simulation but showed various degrees of positivity in at least one of the subsequent tests, thus indicating the onset of an intestinal inflammation. CONCLUSION: Breath tests, especially those 13 C-based, proved suitable for monitoring gastrointestinal motility in the 520-d isolation experiment within MARS-500 project and can be applied in long-term spaceflights.
Author Roda, Aldo
Author_xml – sequence: 1
  givenname: Aldo
  surname: Roda
  fullname: Roda, Aldo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23599647$$D View this record in MEDLINE/PubMed
BookMark eNp1UUtPGzEQtioQBMq9J-RjL5uO7X3YFySEgFbiJQpHZDkbbzLRxg62E8S_r1c8BEjVHDwafw97vj2y5byzhPxgMBZNKX89LWbjDVNjZOWYc5DfyIhzpgouS9giIwbQFErwZpfsxbgA4EJUfIfsclEpVZfNiDxceVeg25iIG0tXxtmeJhtTpJ0PdGZiCh7dMEFnerr0CXtMz7lxmHxAN6NPmOboaJpbenl8-7eoAOhN8Avbpu9kuzN9tAev5z65Pzu9O_ldXFyf_zk5vihaoepUVJ1QbcdaybisJjVnwk4EkzBlipsSSsmBiTKDzFQ1uTolpLXTmlWsBFMJsU-OXnRX68nSTlvrUjC9XgVcmvCsvUH9-cbhXM_8RouaN1JWWeDnq0Dwj-v8W73E2Nq-zwvx66iZEAwUKDl4HX70ejd522kGwAugDT7GYLt3CAM9xKZzbDrHpnNseogtU-ovlBaTSeiH12L_f-I_bWCezg
CitedBy_id crossref_primary_10_1016_j_bios_2018_03_062
crossref_primary_10_1016_j_csbj_2021_03_040
crossref_primary_10_1186_s40168_017_0256_8
crossref_primary_10_1007_s40618_018_0861_9
crossref_primary_10_1111_1541_4337_12633
crossref_primary_10_1113_EP091527
crossref_primary_10_1038_s41598_021_82044_3
crossref_primary_10_1186_s40168_017_0345_8
crossref_primary_10_1089_omi_2015_0181
ContentType Journal Article
Copyright 2013 Baishideng Publishing Group Co., Limited. All rights reserved. 2013
Copyright_xml – notice: 2013 Baishideng Publishing Group Co., Limited. All rights reserved. 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.3748/wjg.v19.i14.2208
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2219-2840
EndPage 2216
ExternalDocumentID PMC3627885
23599647
10_3748_wjg_v19_i14_2208
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
123
29R
2WC
36B
53G
5VR
8WL
92F
92I
AAKDD
AAYXX
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CHBEP
CIEJG
CITATION
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
F5P
FA0
FRP
GX1
HYE
OK1
P2P
RNS
RPM
TCJ
TGQ
TR2
WFFXF
XSB
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c396t-5f39cf1c81285b6213eb3180d192a404820134f39ad97979f938eed615140a533
ISSN 1007-9327
2219-2840
IngestDate Thu Aug 21 14:09:25 EDT 2025
Fri Jul 11 06:13:29 EDT 2025
Mon Jul 21 06:04:29 EDT 2025
Thu Apr 24 23:07:15 EDT 2025
Tue Jul 01 03:21:59 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 14
Keywords Breath test
Gastrointestinal motility
Gastrointestinal inflammation
Spaceflight
Stress
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c396t-5f39cf1c81285b6213eb3180d192a404820134f39ad97979f938eed615140a533
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: Roda A designed the research; Mirasoli M, Simoni P and Festi D developed experimental protocols and materials; Afonin B and Vasilyeva G supervised the experiments during the simulation of a manned mission to Mars; Guardigli M analyzed the data; Roda A, Mirasoli M and Guardigli M wrote the paper; Roda A and Afonin B revised the final version of the paper.
Correspondence to: Aldo Roda, Professor, Department of Chemistry “G. Ciamician”, University of Bologna-Alma Mater Studiorum, Via Selmi 2, Bologna 40126, Italy. aldo.roda@unibo.it
Telephone: +39-51-343398 Fax: +39-51-343398
OpenAccessLink https://doi.org/10.3748/wjg.v19.i14.2208
PMID 23599647
PQID 1331090983
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3627885
proquest_miscellaneous_1331090983
pubmed_primary_23599647
crossref_primary_10_3748_wjg_v19_i14_2208
crossref_citationtrail_10_3748_wjg_v19_i14_2208
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-00-00
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – year: 2013
  text: 2013-00-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World J Gastroenterol
PublicationYear 2013
Publisher Baishideng Publishing Group Co., Limited
Publisher_xml – name: Baishideng Publishing Group Co., Limited
References 10492364 - J Nucl Med. 1999 Sep;40(9):1451-5
9448183 - Am J Gastroenterol. 1998 Jan;93(1):92-8
7801958 - Am J Gastroenterol. 1995 Jan;90(1):93-8
17021896 - Exp Brain Res. 2006 Nov;175(3):377-99
11908886 - Aviat Space Environ Med. 2002 Mar;73(3):206-10
15209531 - Physiol Res. 2004;53(3):245-53
10427653 - Z Gastroenterol. 1999 Jun;37(6):477-81
19505663 - Best Pract Res Clin Gastroenterol. 2009;23(3):337-52
9097998 - Gastroenterology. 1997 Apr;112(4):1155-62
17100982 - Am J Gastroenterol. 2007 Jan;102(1):132-6
12806605 - Gastroenterology. 2003 Jun;124(7):1728-37
15286087 - J Clin Pharmacol. 2004 Aug;44(8):837-53
18350835 - Aviakosm Ekolog Med. 2007 Nov-Dec;41(6):37-43
16534878 - World J Gastroenterol. 2006 Feb 28;12(8):1243-8
15644347 - Ann N Y Acad Sci. 2004 Nov;1027:74-84
12145798 - Gastroenterology. 2002 Aug;123(2):450-60
16474100 - Gut. 2006 Mar;55(3):297-303
22314561 - J Physiol Pharmacol. 2011 Dec;62(6):591-9
22423496 - Aviakosm Ekolog Med. 2011 Nov-Dec;45(6):52-7
12361787 - Nutrition. 2002 Oct;18(10):913-20
14510746 - Aliment Pharmacol Ther. 2003 Oct 1;18(7):721-9
20116352 - Dig Liver Dis. 2010 Aug;42(8):549-53
9675662 - Ital J Gastroenterol Hepatol. 1998 Apr;30(2):211-7
15852539 - J Br Interplanet Soc. 2005 Mar-Apr;58(3-4):117-30
8237860 - Am J Clin Nutr. 1993 Nov;58(5):583-8
19004188 - Adv Clin Chem. 2008;46:87-130
650346 - J Pediatr. 1978 Jul;93(1):62-6
18537637 - Curr Mol Med. 2008 Jun;8(4):299-312
7698571 - Gastroenterology. 1995 Apr;108(4):1048-55
18597588 - Clin Chem Lab Med. 2008;46(9):1275-80
1761729 - J Clin Pharmacol. 1991 Oct;31(10):968-73
17652042 - Dig Liver Dis. 2007 Sep;39(9):795-805
7995201 - Dig Dis Sci. 1994 Dec;39(12 Suppl):107S-109S
8083399 - J Clin Pharmacol. 1994 Jun;34(6):671-6
17727672 - Eur J Clin Invest. 2007 Oct;37(10):802-7
15735075 - J Nutr. 2005 Mar;135(3):437-43
19943520 - Aviakosm Ekolog Med. 2009 Jul-Aug;43(4):39-42
8500721 - Gastroenterology. 1993 Jun;104(6):1640-7
References_xml – reference: 17100982 - Am J Gastroenterol. 2007 Jan;102(1):132-6
– reference: 17727672 - Eur J Clin Invest. 2007 Oct;37(10):802-7
– reference: 14510746 - Aliment Pharmacol Ther. 2003 Oct 1;18(7):721-9
– reference: 18537637 - Curr Mol Med. 2008 Jun;8(4):299-312
– reference: 11908886 - Aviat Space Environ Med. 2002 Mar;73(3):206-10
– reference: 20116352 - Dig Liver Dis. 2010 Aug;42(8):549-53
– reference: 10492364 - J Nucl Med. 1999 Sep;40(9):1451-5
– reference: 12145798 - Gastroenterology. 2002 Aug;123(2):450-60
– reference: 19004188 - Adv Clin Chem. 2008;46:87-130
– reference: 9097998 - Gastroenterology. 1997 Apr;112(4):1155-62
– reference: 15209531 - Physiol Res. 2004;53(3):245-53
– reference: 17652042 - Dig Liver Dis. 2007 Sep;39(9):795-805
– reference: 15286087 - J Clin Pharmacol. 2004 Aug;44(8):837-53
– reference: 7801958 - Am J Gastroenterol. 1995 Jan;90(1):93-8
– reference: 12361787 - Nutrition. 2002 Oct;18(10):913-20
– reference: 8237860 - Am J Clin Nutr. 1993 Nov;58(5):583-8
– reference: 7995201 - Dig Dis Sci. 1994 Dec;39(12 Suppl):107S-109S
– reference: 12806605 - Gastroenterology. 2003 Jun;124(7):1728-37
– reference: 16534878 - World J Gastroenterol. 2006 Feb 28;12(8):1243-8
– reference: 650346 - J Pediatr. 1978 Jul;93(1):62-6
– reference: 15735075 - J Nutr. 2005 Mar;135(3):437-43
– reference: 19505663 - Best Pract Res Clin Gastroenterol. 2009;23(3):337-52
– reference: 22314561 - J Physiol Pharmacol. 2011 Dec;62(6):591-9
– reference: 1761729 - J Clin Pharmacol. 1991 Oct;31(10):968-73
– reference: 19943520 - Aviakosm Ekolog Med. 2009 Jul-Aug;43(4):39-42
– reference: 16474100 - Gut. 2006 Mar;55(3):297-303
– reference: 18350835 - Aviakosm Ekolog Med. 2007 Nov-Dec;41(6):37-43
– reference: 9675662 - Ital J Gastroenterol Hepatol. 1998 Apr;30(2):211-7
– reference: 17021896 - Exp Brain Res. 2006 Nov;175(3):377-99
– reference: 9448183 - Am J Gastroenterol. 1998 Jan;93(1):92-8
– reference: 15852539 - J Br Interplanet Soc. 2005 Mar-Apr;58(3-4):117-30
– reference: 18597588 - Clin Chem Lab Med. 2008;46(9):1275-80
– reference: 10427653 - Z Gastroenterol. 1999 Jun;37(6):477-81
– reference: 8083399 - J Clin Pharmacol. 1994 Jun;34(6):671-6
– reference: 15644347 - Ann N Y Acad Sci. 2004 Nov;1027:74-84
– reference: 8500721 - Gastroenterology. 1993 Jun;104(6):1640-7
– reference: 22423496 - Aviakosm Ekolog Med. 2011 Nov-Dec;45(6):52-7
– reference: 7698571 - Gastroenterology. 1995 Apr;108(4):1048-55
SSID ssj0023352
Score 2.0983913
Snippet To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights. Breath...
To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights.AIMTo...
AIM: To develop an integrated approach for monitoring gastrointestinal motility and inflammation state suitable for application in long-term spaceflights....
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2208
SubjectTerms Acetates - metabolism
Adult
Astronauts
Breath Tests - methods
Brief
Caprylates - metabolism
Carbon Dioxide - metabolism
Carbon Isotopes - metabolism
Feces - chemistry
Gastric Emptying
Gastrointestinal Transit
Humans
Hydrogen - metabolism
Inflammation - immunology
Inflammation - physiopathology
Inflammation Mediators - metabolism
Inulin - metabolism
Leukocyte L1 Antigen Complex - metabolism
Male
Predictive Value of Tests
Space Flight
Time Factors
Weightlessness Simulation
Title Non-invasive panel tests for gastrointestinal motility monitoring within the MARS-500 Project
URI https://www.ncbi.nlm.nih.gov/pubmed/23599647
https://www.proquest.com/docview/1331090983
https://pubmed.ncbi.nlm.nih.gov/PMC3627885
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZb97KXsbFbtm5osJdRnFqWbEuPZbSU0mbQJiwvw_iiZB6pPVy3hf76nSNZrpOW0Y2ACbIsm3M-HX26fSLkMwdaGxRB6DEd5Z5Qi9TLoJX2dAGtvWAyDY2W3skkOpyJo3k4v53BN7tL2myc39y7r-R_vApp4FfcJfsPnu0LhQT4D_6FK3gYrg_y8aSuvLK6Ss0SdKjWerUDzLE1Egs7y_SibWqUg4BajJwTl90Z0n1u6nHjhmG7lY4ne6dnXuj7uHcAB2eGtNUuuRmoTNjCUc-zsSJOOLLw_ag_qOu0LuyA7aqoe5-WTQr2KLstQn17YFG6dDegkp73z5yV-LGW6rZNeVOmw2EKu7_UxrEAgqIHraCdftH3pLlArIaAE8OwGhjxhzvxHrVzwEnXv5bjK6bGJRNjl3VdWnvyLTmYHR8n0_359DF5EsQxC93QTtc7x81neBKh-zI7p41v2N0sf53D3OmYbK6vHRCW6XPyrOtp0D0Lmxfkka5ekh9DyFADGWogQwEydBMy1EGG3kKGWshQgAx1kKEdZF6R2cH-9Ouh152w4eVcRa0XLrjKFywHlifDLAoY1xkEeb8A3p8KCO7oSQGZ0kLF8FsoLoFUIQsWfgo9hddkq6or_ZbQTMkc-F6mFz4XWuosZ7lScSozyTWLoxHZdTZL8k5-Hk9BWSXQDUUrJ2DlBKycgJUTtPKIfOmf-G2lV_6S95NzQwLxESe9wIL15UXCOGrf-kryEXlj3dKXFnAUJxLxiMRrDuszoPb6-p2q_Gk02IH3xVKG7x7w3vfkaWDOUMFxu22y1TaX-gMw2Tb7aBD4B0CYo_I
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non-invasive+panel+tests+for+gastrointestinal+motility+monitoring+within+the+MARS-500+Project&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Roda%2C+Aldo&rft.au=Mirasoli%2C+Mara&rft.au=Guardigli%2C+Massimo&rft.au=Simoni%2C+Patrizia&rft.date=2013&rft.issn=2219-2840&rft.eissn=2219-2840&rft.volume=19&rft.issue=14&rft.spage=2208&rft_id=info:doi/10.3748%2Fwjg.v19.i14.2208&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1007-9327&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1007-9327&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1007-9327&client=summon